Allergan to Buy Kythera Biopharma and Chin Fat Treatment for $2.1B

Botox-maker Allergan has agreed to purchase California-based Kythera Biopharmaceuticals, which is preparing to launch an injection aimed at reducing under-chin fat, in a deal worth approximately $2.1 billion in cash and stock.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news